Lipotoxicity and the gut-liver axis in NASH pathogenesis

被引:597
|
作者
Marra, Fabio [1 ,2 ]
Svegliati-Baroni, Gianluca [3 ,4 ]
机构
[1] Univ Firenze, Dipartimento Med Sperimentale & Clin, Florence, Italy
[2] Univ Firenze, Ctr Ric Denothe, Florence, Italy
[3] Univ Politecn Marche, Dipartimento Sci Clin & Mol, Ancona, Italy
[4] Univ Politecn Marche, Ctr Interdipartimentale Obesita, Ancona, Italy
关键词
Free fatty acids; Ceramides; Apoptosis; JNK; Fibrosis; Inflammasome; Microbiota; Fibroblast growth factor; FXR; Inflammation; INDUCED HEPATIC STEATOSIS; BILE-ACIDS INDUCE; CHAIN FATTY-ACIDS; ENDOPLASMIC-RETICULUM; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; INFLAMMASOME ACTIVATION; EXTRACELLULAR VESICLES; GLUCOSE-PRODUCTION; METABOLIC-RATE;
D O I
10.1016/j.jhep.2017.11.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The pathogenesis of non-alcoholic fatty liver disease, particularly the mechanisms whereby a minority of patients develop a more severe phenotype characterised by hepatocellular damage, inflammation, and fibrosis is still incompletely understood. Herein, we discuss two pivotal aspects of the pathogenesis of NASH. We first analyse the initial mechanisms responsible for hepatocellular damage and inflammation, which derive from the toxic effects of excess lipids. Accumulating data indicate that the total amount of triglycerides stored in hepatocytes is not the major determinant of lipotoxicity, and that specific lipid classes act as damaging agents on liver cells. In particular, the role of free fatty acids such as palmitic acid, cholesterol, lysophosphatidylcholine and ceramides has recently emerged. These lipotoxic agents affect the cell behaviour via multiple mechanisms, including activation of signalling cascades and death receptors, endoplasmic reticulum stress, modification of mitochondrial function, and oxidative stress. In the second part of this review, the cellular and molecular players involved in the cross-talk between the gut and the liver are considered. These include modifications to the microbiota, which provide signals through the intestine and bacterial products, as well as hormones produced in the bowel that affect metabolism at different levels including the liver. Finally, the activation of nuclear receptors by bile acids is analysed. (C) 2017 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
引用
收藏
页码:280 / 295
页数:16
相关论文
共 50 条
  • [1] Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond
    Ohtani, Naoko
    Kamiya, Tomonori
    Kawada, Norifumi
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (09)
  • [2] Current Research on the Pathogenesis of NAFLD/NASH and the Gut-Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
    Kobayashi, Takashi
    Iwaki, Michihiro
    Nakajima, Atsushi
    Nogami, Asako
    Yoneda, Masato
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [3] The gut-liver axis
    Visschers, Ruben G. J.
    Luyer, Misha D.
    Schaap, Frank G.
    Damink, Steven W. M. Olde
    Soeters, Peter B.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2013, 16 (05): : 576 - 581
  • [4] Gut-liver axis
    S. Zeuzem
    International Journal of Colorectal Disease, 2000, 15 : 59 - 82
  • [5] Gut-liver axis
    Zeuzem, S
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2000, 15 (02) : 59 - 82
  • [6] The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
    Seo, Yeon Seok
    Shah, Vijay H.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2012, 18 (04) : 337 - 346
  • [7] Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure
    Zhang, Tao
    Sun, Kewei
    Wang, Ya
    Huang, Lei
    Lang, Ren
    Jiang, Wei
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (02) : 130 - 135
  • [8] NAFLD/MASLD and the Gut-Liver Axis: From Pathogenesis to Treatment Options
    Vallianou, Natalia G.
    Kounatidis, Dimitris
    Psallida, Sotiria
    Vythoulkas-Biotis, Nikolaos
    Adamou, Andreas
    Zachariadou, Tatiana
    Kargioti, Sofia
    Karampela, Irene
    Dalamaga, Maria
    METABOLITES, 2024, 14 (07)
  • [9] The Gut-Liver Axis in Cholestatic Liver Diseases
    Blesl, Andreas
    Stadlbauer, Vanessa
    NUTRIENTS, 2021, 13 (03) : 1 - 32
  • [10] Alcoholic liver disease and the gut-liver axis
    Gyongyi Szabo
    Shashi Bala
    World Journal of Gastroenterology, 2010, 16 (11) : 1321 - 1329